FC

Finepoint Capital Portfolio holdings

AUM $504M
This Quarter Return
+18.43%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$289M
AUM Growth
+$289M
Cap. Flow
+$15.5M
Cap. Flow %
5.38%
Top 10 Hldgs %
61.4%
Holding
42
New
4
Increased
2
Reduced
14
Closed
5

Top Buys

1
MORF
Morphic Holding, Inc. Common Stock
MORF
$16.5M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
$15.4M
3
CLVT icon
Clarivate
CLVT
$11.9M
4
BHC icon
Bausch Health
BHC
$9.32M
5
SLDB icon
Solid Biosciences
SLDB
$2.48M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$17.6M
2
APLS icon
Apellis Pharmaceuticals
APLS
$3.83M
3
ARVN icon
Arvinas
ARVN
$2.01M
4
RLAY icon
Relay Therapeutics
RLAY
$1.82M
5
TVTX icon
Travere Therapeutics
TVTX
$1.74M

Sector Composition

1 Healthcare 95.42%
2 Technology 4.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
APLS icon
1
Apellis Pharmaceuticals
APLS
$3.48B
$22M 7.62% 241,690 -42,000 -15% -$3.83M
PRTA icon
2
Prothena Corp
PRTA
$441M
$21.7M 7.5% 317,300 -14,300 -4% -$976K
ACAD icon
3
Acadia Pharmaceuticals
ACAD
$4.38B
$20.3M 7.02% 846,953 -69,400 -8% -$1.66M
SAGE
4
DELISTED
Sage Therapeutics
SAGE
$16.8M 5.82% 357,765 -31,100 -8% -$1.46M
FOLD icon
5
Amicus Therapeutics
FOLD
$2.34B
$16.7M 5.76% 1,325,775 -134,400 -9% -$1.69M
GLPG icon
6
Galapagos
GLPG
$2.07B
$16.5M 5.72% 406,859 -37,800 -9% -$1.54M
MORF
7
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$16.5M 5.7% +287,556 New +$16.5M
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
$16M 5.52% 608,628 -5,603 -0.9% -$147K
CERE
9
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$15.7M 5.42% 492,545 -46,900 -9% -$1.49M
MLTX icon
10
MoonLake Immunotherapeutics
MLTX
$3.54B
$15.4M 5.33% +302,000 New +$15.4M
CRNX icon
11
Crinetics Pharmaceuticals
CRNX
$2.92B
$14.4M 4.97% 797,527 -70,900 -8% -$1.28M
SRPT icon
12
Sarepta Therapeutics
SRPT
$1.78B
$14.4M 4.97% 125,457 +2,700 +2% +$309K
ASND icon
13
Ascendis Pharma
ASND
$11.8B
$12.5M 4.32% 139,772 -16,300 -10% -$1.45M
CYTK icon
14
Cytokinetics
CYTK
$4.23B
$12M 4.17% 369,093 -44,700 -11% -$1.46M
CLVT icon
15
Clarivate
CLVT
$2.92B
$11.9M 4.11% +1,247,406 New +$11.9M
TVTX icon
16
Travere Therapeutics
TVTX
$1.56B
$11.7M 4.05% 761,721 -113,500 -13% -$1.74M
ARVN icon
17
Arvinas
ARVN
$568M
$10.2M 3.53% 411,500 -80,800 -16% -$2.01M
BHC icon
18
Bausch Health
BHC
$2.74B
$9.32M 3.22% +1,165,000 New +$9.32M
RLAY icon
19
Relay Therapeutics
RLAY
$619M
$8.81M 3.05% 701,570 -144,700 -17% -$1.82M
SLDB icon
20
Solid Biosciences
SLDB
$427M
$5.04M 1.74% 961,251 +472,394 +97% +$2.48M
AAC.WS
21
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$404K 0.14% 504,706 – –
BTWNW
22
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$222K 0.08% 895,000 – –
CCV.WS
23
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$110K 0.04% 612,000 – –
CCVI.WS
24
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$97.2K 0.03% 540,000 – –
CLDI.WS
25
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$85.2K 0.03% 655,200 – –
1
2